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Background: Staphylococcus aureus produces enterotoxins which have potent polyclonal immunostimulatory
effects. IgE directed to these enterotoxins has been detected in serum of asthma, nasal polyp, allergic rhinitis, and
atopic dermatitis patients, but also in serum of healthy subjects. The aim of the study was to assess the association
of sensitization to enterotoxins with chronic rhinosinusitis (CRS), asthma, and atopy presence and severity.
Method: The study was designed as a multicenter, non-matched case-control study, and recruited CRS with
(CRSwNP) and without (CRSsNP) nasal polyps, and controls undergoing septoplasty or conchotomy. Serum was
analyzed for total IgE and for SAE-IgE (SEA, SEC and TSST-1). Sensitization was defined as SAE-IgE > 0.35 kU/L.
Asthma severity was classified according to medication use based on NHLBI guidelines.
Result: 794 serum samples were collected. Of these, 189 were controls, 378 were CRSsNP and 189 were CRSwNP.
Asthma was present in 11.1% of controls, in 19.2% of CRSsNP, and in 39.2% of CRSwNP. Moderate to severe
asthma was present in 7.4% of controls, in 10.2% of CRSsNP and in 28.3% of CRSwNP. SAE-IgE levels were positive
in 15,7 % of controls, in 19.6% of CRSsNP and in 29.6% of CRSwNP. Non-asthmatics had in 19.4% SAE
sensitization, compared to 19,1% of intermittent to mild asthmatics and 40.2% of moderate to severe asthmatics.
Binary logistic regression revealed significant and independent associations of SAE-IgE presence with
moderate-severe asthma and nasal polyposis. When taking in account the titer of SAE-IgE using multinomial logistic
regression, moderate levels of IgE (0.35-1 kU/L) were associated with nasal polyposis and moderate-severe asthma,
whereas high levels (>1 kU/L) were associated with moderate-severe asthma. After controlling for asthma and sinus
disease, atopy was not associated with SAE-IgE.
Conclusion: Serum presence of IgE to staphylococcal enterotoxins was strongly associated with moderate to severe
asthma and nasal polyposis, independently of the presence of atopy. This underlines a potential role for
staphylococcal superantigens in the pathogenesis of severe asthma, nasal polyposis and in their systemic interaction.
